Regeneron Pharmaceuticals Inc (NASDAQ:REGN)

Delayed Data
As of Mar 28
 +6.80 / +0.83%
Today’s Change
Today|||52-Week Range

Stock Price Forecast

The 22 analysts offering 12-month price forecasts for Regeneron Pharmaceuticals Inc have a median target of 891.50, with a high estimate of 1,040.00 and a low estimate of 605.00. The median estimate represents a +7.77% increase from the last price of 827.21.

Analyst Recommendations

The current consensus among 27 polled investment analysts is to Buy stock in Regeneron Pharmaceuticals Inc. This rating has held steady since March, when it was unchanged from a Buy rating.Move your mouse over past
months for detail


Earnings and Sales Forecasts

Current Quarter

Earnings per Share
Reporting Date
May 04

Earnings per Share

Move your mouse over a quarter or year to see how estimates have changed over time.

Growthquarterly -21.84%
Growthannually -7.07%


Growthquarterly -11.92%
Growthannually 4.00%
Key to the earnings and sales forecast charts.